NICDC's Logistics Data Bank achieves milestone of tracking 75 mn containers (See 'Corp Brief') Patents Act - Absence from date of hearing of applicant is not valid ground to believe that Patent application has been abandoned even after filing of First Examination Report: HC (See 'Legal Desk') 13,822 Jan Aushadhi Kendras established across country (See 'Corp Brief') SEBI - Liability depends on role one plays in affairs of company and not on designation or status: SEBI (See 'Legal Desk') CCI approves acquisition of Bharat Serums by Mankind Pharma (See 'Corp Brief') Goyal discusses investment avenues with existing and potential US investors (See 'Corp Brief') Patent Act-Appellant not having been made aware of all grounds of objection and not being afforded sufficient opportunity to contest is violative of principles of natural justice: HC (See 'Legal Desk') Coal production grows by 5.85% in FY 2024-25 (See 'Corp Brief') FCI installs modern video surveillance system in depots (See 'Corp Brief') Foreign Exchange Regulation Act, 1973 -Retracted statement could be relied upon if there existsed corroborative evidence: TRIBUNAL (See 'Legal Desk') FCI transforms supply chain management system under Anna Darpan (See 'Corp Brief') CPC- Judgement of UK court was executable in India as it was covered under exceptions of Section 13 of CPC: HC (See 'Legal Desk') National Institute of Electronics & Information Technology organizes Job Fair 2024 (See 'Corp Brief') SCRA, 1956-non classification of correct shareholder pattern and filing wrong shareholding details leads to violation of provision of SCRA and LODR Regulations attracting monetary penalties: SEBI (See 'Legal Desk') NLC India steps into 10th Year of Renewable Energy Generation (See 'Corp Brief') SARFAESI Act - Issuance of writ in High Court is barred when borrower has simultaneous pending proceeding before DRT or DRAT: HC (See 'Legal Desk') SEBI ACT - Violations and failure to comply with regulatory requirements at time of resignation and appointment of auditors would attract monetary penalty: SEBI (See 'Legal Desk') Scindia inaugurates 5G Open RAN testing Lab at CDoT, Bangalore (See 'Corp Brief') SARFAESI Act- Powers exercisable by CMM under Section 14 are ministerial steps and does not involve any adjudicatory process: HC (See 'Legal Desk') SAIL conducted 52nd Annual General Meeting (See 'Corp Brief') FERA,1973- Connivance by one or more person in execution of illegal act in pursuance of conspiracy is criminal activity defining abetment: TRIBUNAL (See 'Legal Desk') Ministry of Labour, Amazon ink MoU for posting job vacancies & hiring (See 'Corp Brief') Trade Mark- Infringement of registered trademark is required to be considered by examining the overall commercial impression of two marks from standpoint of person of average intelligence and imperfect recollection: HC (See 'Legal Desk') BCCL's strategic moves boost Domestic Coking Coal Consumption (See 'Corp Brief') Constitution of India-Court acting under Article 226 doesnot have power to pass order without proper tangible material : HC (See 'Legal Desk') Make in India celebrates 10 Years (See 'Corp Brief') PMLA-Unaccounted money can at best be tax violation but not offence under Section 3 of PMLA and cannot be termed as POC in absence of any nexus with scheduled offence: HC (See 'Legal Desk')

Print

CCI approves acquisition of Bharat Serums by Mankind Pharma

Published: Oct 03, 2024

By TIOLCorplaws News Service

NEW DELHI, OCT 03, 2024: COMPETITION Commission of India has approved the acquisition of Bharat Serums and Vaccines Limited by Mankind Pharma Ltd. The proposed transaction involves the acquisition of 100% shareholding of Bharat Serums and Vaccines Limited (BSV) by Mankind Pharma Ltd. (Mankind) (Proposed Combination).

Mankind is a public listed company and is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical finished dosage formulations (FDFs) across various acute and chronic therapeutic areas, as well as several consumer healthcare products such as condoms, emergency contraceptives, pregnancy tests, vitamins, minerals, nutrients, antacids and anti-acne preparations segments. Through its subsidiaries, Mankind is also engaged in, inter alia, the manufacture and sale of active pharmaceutical ingredients (APIs), pharmaceutical intermediaries, and packaging products for pharmaceutical products.

BSV, along with its subsidiaries, is engaged in research, development, licensing, manufacturing, importing, exporting, marketing and distribution of: (a) FDFs and APIs; (b) biotech and biological formulations and/or API; (c) food and health supplements; (d) medical devices; and (e) ayurvedic medicines; in each case, in the therapeutic areas such as gynaecology, in-vitro fertilisation, critical care and/or emergency medicines for human use. In India, the activities of BSV (including its wholly owned Indian subsidiary, BSV Pharma Private Limited, which is in the process of merging with BSV) are limited to developing, manufacturing, and marketing a range of biological, biotech, and pharmaceutical products in the therapeutic areas of women's health, critical care, IUI-IVF, and emergency medicine.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
taxindiaonline
A Taxongo Website. Copyright © 2016-2022 tiolcorplaws.com All rights reserved.